Neuberger Berman Group
DERM icon

Neuberger Berman Group’s Journey Medical DERM Stock Holding History

Neuberger Berman Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,036
Closed -$75.2K – 2352
2026
Q1 		$75.2K Buy
16,036
+85
+0.5% +$660 ﹤0.01% 2097
2025
Q4 		$123K Sell
15,951
-3,781
-19% -$29.6K ﹤0.01% 2003
2025
Q3 		$140K Sell
19,732
-2,243
-10% -$16.3K ﹤0.01% 1947
2025
Q2 		$158K Sell
21,975
-750
-3% -$5.18K ﹤0.01% 1929
2025
Q1 		$134K Sell
22,725
-5,770
-20% -$28.4K ﹤0.01% 1854
2024
Q4 		$111K Sell
28,495
-35,899
-56% -$196K ﹤0.01% 1851
2024
Q3 		$364K Sell
64,394
-3,900
-6% -$20.1K ﹤0.01% 1614
2024
Q2 		$385K Sell
68,294
-13,100
-16% -$53.9K ﹤0.01% 1574
2024
Q1 		$300K Sell
81,394
-107,564
-57% -$468K ﹤0.01% 1645
2023
Q4 		$1.09M Buy
188,958
+78,404
+71% +$349K ﹤0.01% 1460
2023
Q3 		$303K Sell
110,554
-9,300
-8% -$20.8K ﹤0.01% 1599
2023
Q2 		$191K Sell
119,854
-8,975
-7% -$14.4K ﹤0.01% 1711
2023
Q1 		$202K Sell
128,829
-3,592
-3% -$6.7K ﹤0.01% 1716
2022
Q4 		$254K Sell
132,421
-29,286
-18% -$57.9K ﹤0.01% 1644
2022
Q3 		$398K Sell
161,707
-35,430
-18% -$121K ﹤0.01% 1530
2022
Q2 		$737K Sell
197,137
-500
-0.3% -$1.98K ﹤0.01% 1378
2022
Q1 		$955K Sell
197,637
-1,475
-0.7% -$7.36K ﹤0.01% 1356
2021
Q4 		$1.07M Buy
+199,112
New +$1.44M ﹤0.01% 1344

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Neuberger Berman Group's DERM Position: Q2 2026 in Review

Neuberger Berman Group sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 16,036 shares — an estimated $75.2K sold.

Neuberger Berman Group first reported a position in DERM in Q4 2021 and held it in 18 quarters. The position peaked at $1.09M in Q4 2023. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Neuberger Berman Group reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • Neuberger Berman Group sold 16,036 Journey Medical shares in Q2 2026, an estimated $75.2K.
  • Neuberger Berman Group first reported a position in Journey Medical in Q4 2021 and held it in 18 quarters.
  • Neuberger Berman Group's Journey Medical position peaked at $1.09M in Q4 2023.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.